1. Ktisis Cyprus University of Technology
  2. Cyprus University of Technology (Research Output)
  3. Άρθρα/Articles
Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/23907
DC FieldValueLanguage
dc.contributor.authorLambrinou, Ekaterini-
dc.contributor.authorDecourcey, Julia-
dc.contributor.authorHill, Loreena Michelle-
dc.date.accessioned2022-02-07T08:28:28Z-
dc.date.available2022-02-07T08:28:28Z-
dc.date.issued2022-01-09-
dc.identifier.citationCurrent Heart Failure Reports, 2022en_US
dc.identifier.issn15469549-
dc.identifier.urihttps://hdl.handle.net/20.500.14279/23907-
dc.description.abstractPurpose of Review: The current review describes the role of the cardio-oncology nurse and the need for personalized heart failure care for the patient with cancer. Recent Findings: It is a new role whereby cardiology or heart failure nurses care for patients with cancer who develop cardiotoxicity or cardiovascular diseases, either during the cancer therapy or in a later stage. Inter-disciplinary approach is important for individualized early treatment, shortened interruptions to cancer therapy, and irreversible cardiovascular injury prevention. Nurses have a key role in early evaluation and quality control of the care provided. Summary: This is a quite new clinical area and not much evidence exists for the development of clinical guidelines and pathways to support clinicians. More trials are needed for the development of clinical recommendations.en_US
dc.formatpdfen_US
dc.language.isoenen_US
dc.relation.ispartofCurrent Heart Failure Reportsen_US
dc.rights© The Author(s).en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCardio-oncology nurseen_US
dc.subjectCardiovascular diseases (CVD)en_US
dc.subjectAnthracyclinesen_US
dc.subjectCardiotoxicityen_US
dc.subjectRazoxaneen_US
dc.titlePersonalizing Heart Failure Care to the Patient With Canceren_US
dc.typeArticleen_US
dc.collaborationCyprus University of Technologyen_US
dc.collaborationKing's College Hospitalen_US
dc.collaborationQueen’s University Belfasten_US
dc.subject.categoryClinical Medicineen_US
dc.journalsOpen Accessen_US
dc.countryCyprusen_US
dc.countryUnited Kingdomen_US
dc.subject.fieldMedical and Health Sciencesen_US
dc.publicationPeer Revieweden_US
dc.identifier.doi10.1007/s11897-021-00536-9en_US
dc.identifier.pmid35000125-
dc.identifier.scopus2-s2.0-85122681802-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85122681802-
cut.common.academicyear2021-2022en_US
item.openairetypearticle-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_6501-
item.languageiso639-1en-
crisitem.author.deptDepartment of Nursing-
crisitem.author.facultyFaculty of Health Sciences-
crisitem.author.orcid0000-0002-2601-8861-
crisitem.author.parentorgFaculty of Health Sciences-
crisitem.journal.journalissn1546-9549-
crisitem.journal.publisherSpringer Nature-
Appears in Collections:Άρθρα/Articles
Files in This Item:
File Description SizeFormat
Lambrinou2022_Article_PersonalizingHeartFailureCareT.pdfFulltext617.81 kBAdobe PDFView/Open
CORE Recommender
Show simple item record

SCOPUSTM   
Citations

1
checked on Feb 2, 2024

WEB OF SCIENCETM
Citations

1
Last Week
0
Last month
0
checked on Oct 29, 2023

Page view(s)

277
Last Week
10
Last month
3
checked on Jan 31, 2025

Download(s) 10

396
checked on Jan 31, 2025

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons